These injections bypass the digestive system, allowing immediate absorption into the bloodstream
doi: 10.1056/NEJMoa1612917 [DOI] [PMC free article] [PubMed] [Google Scholar] 99.Mosterd CM, Bjornstad P, van Raalte DH
There are some potential biases in these data that we need to be cautious about, but this gives us some valuable insights about the risk profile of these agents that can inform subsequent studies perhaps even a randomized controlled trial that can tease out the specific mechanisms and provide more conclusive evidence. Reduced risk overall GLP-1 receptor agonists have been approved in the United States to treat diabetes since 2005 and obesity since 2014
Learn more: To view or add a comment, sign in The Special Issue has been extended
Side effects, particularly nausea and gastrointestinal discomfort are common when starting, but generally improve over time with slow dose escalation
Se sintetiza en el hgado y los riones y se almacena en diversos tejidos del cuerpo, especialmente en los msculos